Evidence map›Paper›PMID 27699091›Full record

ArticleBiomedical optics express2016

Multimodal optical coherence tomography and fluorescence lifetime imaging with interleaved excitation sources for simultaneous endogenous and exogenous fluorescence.

Sebina Shrestha, Michael J Serafino, Jesus Rico-Jimenez, Jesung Park, Xi Chen, Siqin Zhaorigetu, Brian L Walton, Javier A Jo, Brian E Applegate

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Extended Blind End-member and Abundance Extraction for Biomedical Imaging Applications.IEEE access : practical innovations, open solutions · 2019
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sebina ShresthaDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Michael J SerafinoDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Jesus Rico-JimenezDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Jesung ParkDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Xi ChenDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Siqin ZhaorigetuCardiovascular Experimental Imaging and Therapeutics, Texas Heart Institute, 6519 Fannin St., Houston, TX, 77030, USA.
Brian L WaltonCardiovascular Experimental Imaging and Therapeutics, Texas Heart Institute, 6519 Fannin St., Houston, TX, 77030, USA.
Javier A JoDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Brian E ApplegateDepartment of Biomedical Engineering, Texas A&M University, 5045 Emerging Technology Building, College Station, TX, 77843, USA.
Texas A&M University · US

Funding

Morphological and Molecular Imaging System for in vivo Atherosclerosis ResearchR01HL111361 · NHLBI · TEXAS ENGINEERING EXPERIMENT STATION · PI APPLEGATE, BRIAN E. · 2012 to 2016
$1.7M
NHLBI NIH HHS R01 HL111361
6 · The paper itself

Abstract

Multimodal imaging probes a variety of tissue properties in a single image acquisition by merging complimentary imaging technologies. Exploiting synergies amongst the data, algorithms can be developed that lead to better tissue characterization than could be accomplished by the constituent imaging modalities taken alone. The combination of optical coherence tomography (OCT) with fluorescence lifetime imaging microscopy (FLIM) provides access to detailed tissue morphology and local biochemistry. The optical system described here merges 1310 nm swept-source OCT with time-domain FLIM having excitation at 355 and 532 nm. The pulses from 355 and 532 nm lasers have been interleaved to enable simultaneous acquisition of endogenous and exogenous fluorescence signals, respectively. The multimodal imaging system was validated using tissue phantoms. Nonspecific tagging with Alexa Flour 532 in a Watanbe rabbit aorta and active tagging of the LOX-1 receptor in human coronary artery, demonstrate the capacity of the system for simultaneous acquisition of OCT, endogenous FLIM, and exogenous FLIM in tissues.

Indexed as

(110.4500) Optical coherence tomography(120.3890) Medical optics instrumentation(170.0110) Imaging systems(170.2520) Fluorescence microscopy

Identifiers

PMID27699091
PMCPMC5030003
OpenAlexW2494943714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.